Current stock price

Investor Relations

GCANRx is a publicly traded biotechnology company led by an experienced team of executives and scientists. The company is focused on the the development and commercialization of innovative Cannabinoid delivery systems.

OCT 07, 2022

GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders

Dec 16, 2021

GCANRx Strategic Advisor Dr. Adi Aran to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special

Dec 02, 2021

GCANRx Appoints Renowned Cannabinoid Researcher Dr. Adi Aran as Strategic Advisor

Corporate Presentation

See our latest corporate presentation.

Stock Information

See our current stock performance.


Aitan Zacharin

Aitan Zacharin


Aitan Zacharin is an experienced executive with a broad knowledge in building and managing biopharmaceutical, healthcare, technology, and consumer products businesses. Mr. Zacharin founded and was responsible for the growth of multiple companies from seed stage to listings on the US public markets.

David Tavor


Chief Scientific Advisor

Certified pediatrics neurology sub-specialist since 2007, completed a postdoctoral research fellowship in Stanford, CA.

Director of the pediatric neurology unit at Shaare Zedek Medical Center in Jerusalem and specializes in the diagnosis and treatment ASD.

Hock S. Tan



Extensive track record in healthcare and finance sector. Motti was part of the team that managed one of Bank Leumi's, Israel’s largest bank’s, biggest business divisions.

More about our management

SEC Filings

Apr 03, 2023

Form NT 10-K

NOV 21, 2022

Form PRE 14A


What is the ticker symbol for GCANRx?

Shares of GCANRx are traded on the OTC Markets under the ticker symbol GCAN.

Where is GCANRx’s corporate headquarters?

GCANRx is based out of Baltimore, MD.

When does GCANRx’s fiscal year end?

December 31.

Who is GCANRx’s transfer agent?

Worldwide Stock Transfer, LLC
One University Plaza Suite 505 Hackensack, NJ 07601. (201) 820-2008.

Who is GCANRx’s auditor?

OLAYINKA OYEBOLA & CO (Chartered Accountants)

What is GCANRx's CUSIP number?


What is GCANRx's CIK Number?


What is GCANRx's SIC and Classification?

2834; Pharmaceutical Preparations

What is GCANRx's O/S and Float?

804,638,436 as of 9/30/23

Sign up for email alerts

Stay up to date on the latest news.


* indicates required